Skip to main content

UBS Group AG

Position in IDXGD — Interpace Biosciences, Inc.

CIK 1610520 ZURICH, V8

Position in IDXGD

as of Dec 31, 2020 · filed Feb 11, 2021
Position Value
$0
+$0 QoQ
Shares Held
2,946
-15.1% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IDXGD Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

UBS Group AG holds $4,492,966,338 across 42 Diagnostics & Research names.

# Ticker Company Shares Value (USD) Open

All Filings in IDXGD

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2020-12-31 2,946
2020-09-30 3,472
2020-03-31 1,390